Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-064-6 | CAS number: 628-97-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Based on the current litterature and the available information of these substances, the ethyl palmitate was not considered to be bioaccumlable in organism.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Similar toxicokinetic behavior
The fatty acid esters of this C14-C18 category are considered to undergo hydrolysis in the gastrointestinal (GI) tract by ubiquitous expressed GI enzymes (Lehninger, 1970; Mattson and Volpenhein, 1972). The breakdown products of ester hydrolysis are free alcohols (isopropanol, (iso)butanol and ethanol) and the respective free fatty acids with carbon chain length from C14-C18, mainly satured but also unsatured. Due to their physical-chemical properties, the main route of exposure of the fatty acid esters of the category is via the oral route.
Absorption
The absorbed esters undergo stepwise chemical changes in the gastrointestinal fluids as a result of enzymatic hydrolysis. The respective alcohols as well as the fatty acid are formed (Mattson and Volpenhein, 1972). For both cleavage products absorption will occur in the gastrointestinal tract: The highly lipophilic fatty acid is absorbed by micellar solubilization (Ramirez et al. 2001), soluble alcohol are dissolved in pancreatic juice and the ester can be distributed.
Dermal absorption:
According to the current literature, esterase enzymes are present into the skin of different mammalian species (as human, rodents or minpigs). These enzymes, as carboxylesterase, hydrolyzed different substrates as xenobiotic or different ester as fatty acids esters (C. Jewell, 2007; J.J. Prusakiewicz, 2006). Based on this principle, when applied on skin, the source and the target substances are expected to be substrates of these carboxylesterase. They are hydrolyzed into fatty acids and alcohols. In the case that the hydrolysis products cross the dermal barrier to reach systemic system, they would have the same behavior as after oral ingestion. The potential toxicity should originate from these hydrolyzed products.
Distribution
The high log Pow value of the category members implies that they have the potential to accumulate in adipose tissue. However, as they undergo esterase-catalysed hydrolysis, the accumulation of the cleavage products has to be considered. Substances with high water solubility, like the alcohols do not have the potential to accumulate in adipose tissue due to their low log Pow : the alcohol components have low molecular weights (from 46.07 to 74.1 g/mol) and high to moderate water solubility (In water, 66 to 68g/L for(iso)butanol and highly soluble for ethanol and isopropanol) and will therefore be widely distributed within the body (ECHA, 2008; HSDB, 2011; Amidon GL, 1974 citated in HSDB). In contrast, accumulation of the fatty acids in triglycerides in adipose tissue or the incorporation into cell membranes is possible. Overall, the available information that they were required as energy source, indicates that no significant bioaccumulation in adipose tissue is anticipated.
Metabolisation
Esters of fatty acids are hydrolysed to the corresponding alcohol and fatty acid by esterases (Fukami and Yokpo, 2012). Depending on the route of exposure, esterase-catalysed hydrolysis takes place in different places in the organism: after oral ingestion, esters of alcohol and fatty acids undergo enzymatic hydrolysis already in GI fluids. In contrast, substances that are absorbed through the pulmonary alveolar membrane or through the skin enter the systemic circulation directly before joining the liver where hydrolysis basically takes place. The first cleavage product, the alcohol, is oxidized in several steps by the nonspecific alcohol dehydrogenase and the aldehyde dehydrogenase to the corresponding aldehyde and alcohol. Glucuronidation will also take place at all steps to facilitate urinary excretion (HSDB, 2011). The second cleavage product, the fatty acid, is stepwise degraded by beta-oxydation based on enzymatic removal of C2 units in the matrix of mitochondria in most vertebrate tissues. The C2 units are cleaved as acyl-CoA, the entry molecular of citric acid cycle. The omega- and alpha-oxydation, alternative pathways for oxidation can be found in the liver and the brain, respectively.
Based on the metabolism described, the fatty acids esters and the breakdown products will be metabolised in the body in high extent. The fatty acid components will be metabolized for energy generation or stored as lipid in adipose tissue or used for further physiological properties as incorporation in lipid cell membranes (Lehninger 1970; Stryer 1994).
Excretion
The fatty acid component are not expected to be excreted to a significant degree via urine or faeces but excreted via exhaled air as CO2 or stored. The second route of excretion is expected to be by biliary excretion within the faeces. For the alcohol, the main route is renal excretion via the urine due to the low molecular weight and the high water solubility (HSDB, 2011).
Based on all data available on different similar substance of this category, these substances have toxicokinetic similarity and common pathways
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.